behavior · clinical
Reference snapshot
This snapshot describes the state of the editorial record, not a diagnosis or a recommendation to intervene.
Claim ledger
Support not yet mapped. These editorial statements retain their original wording; related topic sources are available separately and have not been assigned as claim-specific support.
Signal
Digital therapeutics now show strongest signals in adherence, self-management, and longitudinal tracking workflows.
Boundary
Moderate to high in approved pathways; lower in open consumer stacks.
Not established
Linked records do not establish a universal digital therapeutics protocol, diagnosis, or guaranteed outcome.
Mechanism map (working model)
A simplified causal map for orientation; it is not a diagnosis or a deterministic prediction.
Input or intervention
Digital Therapeutics
Biological pathway
behavior pathway shaped by dose, context, and individual response
Measurable signal
Evidence-backed software systems for habit, stress, pain, sleep, and metabolic behavior support.
Boundary
Dependency on app quality and algorithmic bias; not a substitute for medical care.
Research appraisal checklist
Evidence to prioritize
Indication-specific clinical trials, patient-important outcomes, active comparators, safety monitoring, and follow-up long enough to test durability.
Outcome anchor
Separate symptom or biomarker movement from improved function, quality of life, disease control, or another outcome that matters to patients.
Main uncertainty
The main uncertainty is how much the result depends on diagnosis, product, dose, supervision, selection, and delivery setting.
What would change the conclusion
Upgrade confidence only when independent studies reproduce the result and make harms, adherence, and durability visible.
Minimum diligence questions
- Are the intervention, dose or exposure, comparator, population, and measurement conditions clearly defined?
- Do the outcomes matter outside the experiment, and are missing data, adverse events, and conflicts visible?
- Can the result be reproduced independently, and does it justify the level of risk being discussed?
Application and translation pathway
Current application boundary
Digital Therapeutics is currently best understood as a clinical behavior domain; practical use should stay within the evidence and safety boundary described in this dossier.
Research and applied uses
- Measurement and hypothesis testing in behavior
- Protocol design with defined outcomes and context
- Low-risk applied experimentation with reversible changes
A staged map for separating an interesting mechanism from a reproducible, useful, and responsibly deployable application.
Question
Define the population, intervention, comparator, and outcome before interpreting a signal.
Signal
Check measurement validity, adherence, confounding, and whether the result repeats.
Function
Ask whether the change improves meaningful daily function or clinical outcomes.
Boundary
Preserve normal functioning and stop when symptoms or risk increase.
Research and clinical readout
Research status
Digital therapeutics now show strongest signals in adherence, self-management, and longitudinal tracking workflows.
Signal confidence
Grade B (Moderate to high in approved pathways; lower in open consumer stacks.)
Key question
Which outcomes are clinically meaningful versus engagement metrics?
Clinical perspective
Good fit when used as structured, low-risk support around established care pathways.
Clinical uncertainty
Quality of algorithms and escalation logic varies widely across products.
Community patterns
Most use success patterns are tied to habit triggers, reminders, and weekly review habits.
Common community failure mode
Dropoff in adherence after novelty wears off.
Where this is heading
Expect tighter integration with remote monitoring and clinician dashboards, but only with stronger interoperability standards.
What to track next
Evidence-backed software systems for habit, stress, pain, sleep, and metabolic behavior support.
Protocol and safety scaffold
Risk gate: Start with low-risk foundations and preserve normal functioning while testing one variable.
Baseline first
- Define one meaningful outcome and a comparison window before changing the protocol.
- Record relevant symptoms, sleep, workload, medications, and confounders at baseline.
Implementation pattern
- Change one variable at a time and use the smallest meaningful intervention.
- Predefine review, washout, and escalation criteria before looking at results.
Monitor
- Track the target outcome alongside symptoms, function, and adherence.
- Check data quality and context before treating a change as a signal.
Pause or stop rules
- Pause for new or worsening symptoms, reduced normal function, or a meaningful safety concern.
- Pause signal: Treating serious symptoms without clinician oversight.
Clinician gate
Use clinician review for persistent symptoms, medication changes, abnormal results, pregnancy, or a diagnosed medical condition.
Glossary connections
Controversies to monitor
Controversies
- Outcome substitution (usage metrics replacing health outcomes).
- Weak escalation when users worsen clinically.
Core reference classes
Research classes
- Clinical deployment and adherence trials
- Digital behavior intervention meta-analyses
Evidence timeline
Linked records are ordered by publication year. A newer record is not automatically stronger; design, population, and endpoint still determine weight.
Digital Twins in Healthcare: Current Applications, Frameworks, and Future Directions
Digital Health / PubMed - Systematic review
A 2026 systematic review maps digital-twin applications in diagnostics, therapy optimization, monitoring, and health systems while identifying validation and implementation gaps.
View source recordBelief Effects in Health Interventions
Health Psychology Review / PubMed - Scoping review
A 2026 scoping review maps individual, practitioner, relationship, intervention, and setting factors that shape expectations and belief-related health outcomes.
View source recordBehavioral Interventions for Psychological and Sleep Symptoms During Menopause
Acta Psychologica / PubMed - Systematic review
A 2026 systematic review synthesizes cognitive-behavioral, acceptance-based, and mindfulness-based interventions for psychological and sleep-related symptoms during the menopausal transition.
View source recordEfficacy of Slow-Paced Breathing as a Just-in-Time Adaptive Intervention for Anxiety
PubMed - Randomized controlled study
A randomized study tests slow-paced breathing delivered at moments of need for anxiety, offering a bridge between breathwork and adaptive digital support while leaving durability and broad clinical use open.
View source recordDrug Repurposing
U.S. Food and Drug Administration - Regulatory initiative and research resource
FDA describes current efforts to identify and support new uses for approved drugs when evidence can support clinically meaningful labeling and unmet-need pathways.
View source recordA Systematic Review on Wearable-Enabled Remote Health Monitoring
Digital Health / PubMed - Systematic review
A 2026 review of 55 studies reports growing use of wearables in remote monitoring while calling for more rigorous clinical trials and stronger integration methods.
View source recordDigital Twin and Medical Modeling Literature
Nature Reviews Bioengineering - Perspective / review
Use modeling papers, reviews, and implementation reports to track readiness levels and safety boundaries for physiology-modeling systems.
View source recordContinuous Glucose Monitoring Versus Self-Monitoring in Type 2 Diabetes
Canadian Journal of Diabetes / PubMed - Randomized controlled trial
A multicenter randomized trial in adults with type 2 diabetes using basal insulin and modern therapies found improved glycemic control with real-time continuous glucose monitoring versus self-monitoring; the result should not be generalized to healthy users seeking optimization.
View source recordWearable Aptamer Patch for Continuous Drug Concentration
Nature Biotechnology / PubMed - Pilot phase clinical trial
A pilot study in six healthy participants tested a wearable electrochemical aptamer patch that measured vancomycin in dermal interstitial fluid at five-minute resolution; sensor degradation limited the most interpretable data window.
View source recordTechnology-Assisted Behavior Change for Activity, Diet, Stress, and Sleep
PLOS One / PubMed - Randomized controlled trial
A randomized clinical trial compared technology-assisted coaching and modest incentives targeting physical activity and diet with an intervention targeting stress and sleep, using repeated smartphone-based self-report; engagement, adherence, and self-reported outcomes remain important to interpretation.
View source recordVirtual-Reality Cognitive Remediation for Mood and Psychosis Spectrum Disorders
The Lancet Digital Health / PubMed - Single-centre double-blind randomized controlled trial
A randomized trial compared immersive virtual-reality cognitive remediation with a virtual-reality control in people with mood or psychosis spectrum disorders, testing cognition and functioning after an intensive defined program; the diagnosis, content, comparator, and follow-up constrain generalization.
View source recordWearable-Informed Digital Intervention for Depression and Anxiety
npj Digital Medicine / PubMed - Randomized controlled study
A decentralized randomized study of a digital intervention combining wearable data with mobile cognitive-behavioral support reported symptom improvements over 16 weeks; independent replication and longer follow-up remain important.
View source recordWearable Transcranial Photobiomodulation for Depression and Sleep
Journal of Affective Disorders / PubMed - Randomized double-blind sham-controlled trial
A randomized sham-controlled trial evaluated a self-administered wearable transcranial photobiomodulation device in major depressive disorder and sleep outcomes; device parameters, diagnosis, and trial context matter when interpreting consumer claims.
View source recordSmartphone Assessment and AI-Generated Personalized Exercise
Journal of Medical Internet Research / PubMed - Randomized controlled trial
A randomized trial in healthy older adults tested smartphone motor assessment with machine-learning-tailored exercise and reported improvements in selected balance, flexibility, and strength outcomes over eight weeks.
View source recordPsychedelics and MDMA for Mental Disorders: Living Systematic Review
PubMed / Living systematic review - Living systematic review and meta-analysis of randomized trials
A living review synthesized randomized trials of serotonergic psychedelics and MDMA for mental disorders, emphasizing indication-specific effects, low or very-low certainty in several comparisons, high risk of bias, psychological support, and limited long-term evidence.
View source recordEfficacy and Safety of Esketamine for Treatment-Resistant Depression: Individual Patient Data Meta-Analysis
BMC Medicine / PubMed - Registered systematic review and individual-patient-data meta-analysis
An individual-patient-data reanalysis of randomized trials found a statistically significant but modest average benefit for esketamine plus an antidepressant at four weeks, with increased sedation, dissociation, and adverse events and uncertainty about clinical magnitude.
View source recordTopic assessment
These questions test evidence interpretation and safety boundaries, not personal medical decisions.
1. What is the most defensible first question when evaluating Digital Therapeutics?
Show answer and explanation
What outcome, evidence, and risk boundary are defined?
A clear outcome, evidence design, and risk boundary keep an encyclopedia claim from becoming an unsafe recommendation.
2. What would make a claim about Digital Therapeutics more trustworthy?
Show answer and explanation
Replication with appropriate controls, context, and meaningful outcomes
Reproducibility and patient-important outcomes matter more than novelty, complexity, or an isolated signal.
Editorial update history
This log records what changed in the encyclopedia record and why the update matters for interpretation.
A-Z topic scaffolding, safety framing, learning paths, and linked evidence architecture established for the living encyclopedia.
Added current records spanning real-world digital cohorts, multi-omics, serum proteomics, sweat biosensing, peptides, aging clocks, kinase signaling, endocrine research, personalized nutrition, microbiome response, neurotechnology, and caloric restriction.
Related record update: Wearable Aptamer Patch for Continuous Drug Concentration
Added recent human records on microbiome-based insomnia treatment, online-guided activity and cognition, technology-assisted behavior change, and next-generation epigenetic aging clocks, with explicit translation and conflict boundaries.
Related record update: Technology-Assisted Behavior Change for Activity, Diet, Stress, and Sleep
Added explicit dossiers for bioelectronic medicine, cellular reprogramming, microbiome engineering, organoid modeling, AI-assisted protein design, regenerative medicine, sensory substitution, and virtual-reality therapeutics, then linked current reviews, clinical studies, translational models, and early human neurotechnology evidence with explicit safety boundaries.
Related record update: Virtual-Reality Cognitive Remediation for Mood and Psychosis Spectrum Disorders
Added encyclopedia coverage for breathwork, creatine cognition, intermittent hypoxia, ketogenic metabolism, mindfulness and interoception, nootropics, photobiomodulation, and psychedelic-assisted therapy, with topic-specific safety framing and current evidence links.
Related record update: Psychedelics and MDMA for Mental Disorders: Living Systematic Review
Added dossiers for ketamine and esketamine, sleep apnea, cuffless blood pressure, extracellular vesicles, exercise mimetics, postbiotics, nutritional psychiatry, and plasma-exchange rejuvenation claims, with clinical boundaries, community-risk framing, and current research links.
Related record update: Efficacy and Safety of Esketamine for Treatment-Resistant Depression: Individual Patient Data Meta-Analysis
Added dossiers for brain-computer interfaces, sweat biosensing, digital twins for precision health, and metabolic flexibility, connecting technical progress to clinical translation, measurement validity, uncertainty, and community safety boundaries.
Related record update: Digital Twins in Healthcare: Current Applications, Frameworks, and Future Directions
Added hyperbaric oxygen, wearable drug sensing, and menopause cognition and sleep coverage, connecting clinical indications to device safety, individualized treatment, symptom outcomes, and boundaries around anti-aging or enhancement claims.
Related record update: Wearable Aptamer Patch for Continuous Drug Concentration; Behavioral Interventions for Psychological and Sleep Symptoms During Menopause
Added indication-specific testosterone and male-fertility coverage alongside N-of-1 trial design and placebo, expectancy, and nocebo literacy, with explicit clinical gates and causal-inference boundaries.
Related record update: Belief Effects in Health Interventions
Added evidence-aware dossiers for dopamine and reward learning, neuroplasticity and cognition, allostatic load and chronic stress, and slow breathing with HRV biofeedback, separating mechanisms, subjective effects, functional outcomes, and safety boundaries.
Related record update: Efficacy of Slow-Paced Breathing as a Just-in-Time Adaptive Intervention for Anxiety
Added dedicated dossiers for vitamin and micronutrient repletion, peptide therapeutics and research-grade compounds, off-label medication repurposing, and compounded or online-sourced medications, with current nutrition evidence, human peptide pharmacology, FDA labeling resources, and product-quality boundaries.
Related record update: Drug Repurposing
Linked evidence records
Digital Twins in Healthcare: Current Applications, Frameworks, and Future Directions
Digital Health / PubMed • Systematic review • Published: 2026 • Checked: Aug 17, 2026
A 2026 systematic review maps digital-twin applications in diagnostics, therapy optimization, monitoring, and health systems while identifying validation and implementation gaps.
How to interpret this record
What it supports
Digital-twin applications are being studied across diagnosis, therapy optimization, physiological monitoring, and health-system modeling.
Major limitations
Studies use varied definitions, data sources, validation methods, and outcomes; privacy, cost, implementation, and uncertainty remain important barriers.
What it does not establish
A personalized model does not automatically provide a validated treatment recommendation or improve outcomes over usual care.
Belief Effects in Health Interventions
Health Psychology Review / PubMed • Scoping review • Published: 2026 • Checked: Aug 17, 2026
A 2026 scoping review maps individual, practitioner, relationship, intervention, and setting factors that shape expectations and belief-related health outcomes.
How to interpret this record
What it supports
Individual, practitioner, relational, intervention, and setting factors can shape expectations and belief-related health outcomes.
Major limitations
The review is hypothesis-generating across varied domains and does not predict the size or direction of an individual's response.
What it does not establish
Expectancy effects do not mean symptoms are imaginary or that the active intervention has no biological effect.
Behavioral Interventions for Psychological and Sleep Symptoms During Menopause
Acta Psychologica / PubMed • Systematic review • Published: 2026 • Checked: Aug 17, 2026
A 2026 systematic review synthesizes cognitive-behavioral, acceptance-based, and mindfulness-based interventions for psychological and sleep-related symptoms during the menopausal transition.
How to interpret this record
What it supports
CBT, acceptance-based, and mindfulness-based interventions show a research signal for selected psychological and sleep-related menopause outcomes.
Major limitations
Intervention format, adherence, comparator, symptom profile, and follow-up vary, and behavioral benefit is not identical to hormone or disease-modifying benefit.
What it does not establish
A behavioral intervention is not a substitute for evaluation of severe depression, suicidality, abnormal bleeding, neurological symptoms, or other medical causes.
Efficacy of Slow-Paced Breathing as a Just-in-Time Adaptive Intervention for Anxiety
PubMed • Randomized controlled study • Published: 2026 • Checked: Aug 17, 2026
A randomized study tests slow-paced breathing delivered at moments of need for anxiety, offering a bridge between breathwork and adaptive digital support while leaving durability and broad clinical use open.
How to interpret this record
What it supports
A just-in-time slow-breathing intervention can be tested as an adaptive support tool for anxiety in a controlled study.
Major limitations
Early digital-intervention evidence does not establish durability, broad generalization, or superiority to usual care across anxiety disorders.
What it does not establish
An app prompt or brief breathing exercise is not a diagnosis or a guarantee of safety during severe anxiety, syncope, or breathing symptoms.
Drug Repurposing
U.S. Food and Drug Administration • Regulatory initiative and research resource • Published: 2026 • Checked: Aug 17, 2026
FDA describes current efforts to identify and support new uses for approved drugs when evidence can support clinically meaningful labeling and unmet-need pathways.
How to interpret this record
What it supports
Drug repurposing can use existing pharmacology and safety knowledge to investigate unmet needs and potentially support future labeling changes.
Major limitations
Repurposing hypotheses still require indication-specific clinical evidence, appropriate comparators, monitoring, and regulatory translation.
What it does not establish
A drug's known mechanism, prior approval, or case report does not prove that it improves a new disease or wellness outcome.
A Systematic Review on Wearable-Enabled Remote Health Monitoring
Digital Health / PubMed • Systematic review • Published: 2026 • Checked: Aug 17, 2026
A 2026 review of 55 studies reports growing use of wearables in remote monitoring while calling for more rigorous clinical trials and stronger integration methods.
How to interpret this record
What it supports
Wearables are being integrated into remote monitoring and feedback workflows, with personalization as an active research priority.
Major limitations
The review identifies a need for more rigorous clinical trials and does not make all consumer devices equivalent.
What it does not establish
Engagement or monitoring capability does not prove improved health outcomes.
Digital Twin and Medical Modeling Literature
Nature Reviews Bioengineering • Perspective / review • Published: 2026 • Checked: Aug 17, 2026
Use modeling papers, reviews, and implementation reports to track readiness levels and safety boundaries for physiology-modeling systems.
How to interpret this record
What it supports
Modeling systems can organize physiology, validation, interoperability, and governance questions.
Major limitations
A model can be technically sophisticated while remaining poorly calibrated or clinically unvalidated.
What it does not establish
A digital twin does not automatically provide a safe individualized treatment recommendation.
Continuous Glucose Monitoring Versus Self-Monitoring in Type 2 Diabetes
Canadian Journal of Diabetes / PubMed • Randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A multicenter randomized trial in adults with type 2 diabetes using basal insulin and modern therapies found improved glycemic control with real-time continuous glucose monitoring versus self-monitoring; the result should not be generalized to healthy users seeking optimization.
How to interpret this record
What it supports
Real-time CGM improved glycemic control versus self-monitoring in the studied adults with type 2 diabetes under clinician-supported care.
Major limitations
The trial involved a defined clinical population, open-label treatment, and medication context that may not transfer to healthy biohacking use.
What it does not establish
CGM use in a clinical diabetes trial does not prove benefit from continuous glucose monitoring for every healthy user.
Wearable-Informed Digital Intervention for Depression and Anxiety
npj Digital Medicine / PubMed • Randomized controlled study • Published: 2025 • Checked: Aug 17, 2026
A decentralized randomized study of a digital intervention combining wearable data with mobile cognitive-behavioral support reported symptom improvements over 16 weeks; independent replication and longer follow-up remain important.
How to interpret this record
What it supports
A wearable-informed digital intervention showed symptom improvements in a randomized study of adults with depression or generalized anxiety symptoms.
Major limitations
The intervention included cognitive-behavioral content and app engagement, so effects cannot be attributed to passive sensing alone; long-term and independent replication remain open.
What it does not establish
Wearable data alone is not a mental-health treatment or autonomous clinical decision system.
Wearable Transcranial Photobiomodulation for Depression and Sleep
Journal of Affective Disorders / PubMed • Randomized double-blind sham-controlled trial • Published: 2025 • Checked: Aug 17, 2026
A randomized sham-controlled trial evaluated a self-administered wearable transcranial photobiomodulation device in major depressive disorder and sleep outcomes; device parameters, diagnosis, and trial context matter when interpreting consumer claims.
How to interpret this record
What it supports
A sham-controlled trial provides early clinical evidence to assess a specific wearable transcranial photobiomodulation protocol for depression and sleep outcomes.
Major limitations
Results are device-, dose-, diagnosis-, and trial-specific; broader effectiveness, durability, and real-world safety need further study.
What it does not establish
One device trial does not establish broad cognitive enhancement or a general-purpose home neurostimulation protocol.
Smartphone Assessment and AI-Generated Personalized Exercise
Journal of Medical Internet Research / PubMed • Randomized controlled trial • Published: 2025 • Checked: Aug 17, 2026
A randomized trial in healthy older adults tested smartphone motor assessment with machine-learning-tailored exercise and reported improvements in selected balance, flexibility, and strength outcomes over eight weeks.
How to interpret this record
What it supports
Smartphone motor assessment paired with tailored exercise improved selected functional outcomes in the studied healthy older adults.
Major limitations
Results were population-, program-, and outcome-specific, with a relatively short intervention and no proof that every algorithmic plan is superior.
What it does not establish
AI-generated exercise is not automatically individualized medical care or a substitute for professional evaluation when risk is present.
Wearable Aptamer Patch for Continuous Drug Concentration
Nature Biotechnology / PubMed • Pilot phase clinical trial • Published: 2026 • Checked: Aug 17, 2026
A pilot study in six healthy participants tested a wearable electrochemical aptamer patch that measured vancomycin in dermal interstitial fluid at five-minute resolution; sensor degradation limited the most interpretable data window.
How to interpret this record
What it supports
A small human pilot demonstrates feasibility of wearable interstitial-fluid drug sensing at high temporal resolution for a defined drug and patch design.
Major limitations
Only six healthy participants were studied, sensor degradation narrowed the usable window, and performance was not established for routine therapeutic dosing decisions.
What it does not establish
A prototype patch does not replace validated blood testing, therapeutic-drug monitoring, or clinician-directed medication management.
Technology-Assisted Behavior Change for Activity, Diet, Stress, and Sleep
PLOS One / PubMed • Randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A randomized clinical trial compared technology-assisted coaching and modest incentives targeting physical activity and diet with an intervention targeting stress and sleep, using repeated smartphone-based self-report; engagement, adherence, and self-reported outcomes remain important to interpretation.
How to interpret this record
What it supports
Technology-assisted coaching can be evaluated with repeated behavioral, stress, sleep, diet, and activity measures over time.
Major limitations
Self-report, incentives, engagement, intervention content, and adherence can influence results; digital coaching effects are not equivalent to clinical treatment for persistent symptoms.
What it does not establish
A smartphone intervention does not establish a universal behavior-change effect or replace evaluation for clinically significant sleep, mood, or medical problems.
Virtual-Reality Cognitive Remediation for Mood and Psychosis Spectrum Disorders
The Lancet Digital Health / PubMed • Single-centre double-blind randomized controlled trial • Published: 2026 • Checked: Aug 17, 2026
A randomized trial compared immersive virtual-reality cognitive remediation with a virtual-reality control in people with mood or psychosis spectrum disorders, testing cognition and functioning after an intensive defined program; the diagnosis, content, comparator, and follow-up constrain generalization.
How to interpret this record
What it supports
A defined randomized trial provides indication-specific evidence for an immersive virtual-reality cognitive-remediation program with an active virtual-reality control.
Major limitations
Diagnosis, intervention intensity and content, comparator, follow-up, transfer to daily function, and setting constrain generalization beyond the studied population and program.
What it does not establish
The trial does not establish universal cognitive enhancement or replacement for assessment and treatment of psychiatric conditions.
Psychedelics and MDMA for Mental Disorders: Living Systematic Review
PubMed / Living systematic review • Living systematic review and meta-analysis of randomized trials • Published: 2025 • Checked: Aug 17, 2026
A living review synthesized randomized trials of serotonergic psychedelics and MDMA for mental disorders, emphasizing indication-specific effects, low or very-low certainty in several comparisons, high risk of bias, psychological support, and limited long-term evidence.
How to interpret this record
What it supports
A living synthesis of randomized trials helps track indication-specific efficacy, psychological support, control conditions, adverse events, and certainty in psychedelic and MDMA research.
Major limitations
Many trials have high risk of bias, small samples, variable support, difficult blinding, and limited long-term follow-up; legal and clinical access also differ by jurisdiction.
What it does not establish
The review does not establish unsupervised use, microdosing, retreats, or self-treatment as safe or effective psychiatric care.
Efficacy and Safety of Esketamine for Treatment-Resistant Depression: Individual Patient Data Meta-Analysis
BMC Medicine / PubMed • Registered systematic review and individual-patient-data meta-analysis • Published: 2025 • Checked: Aug 17, 2026
An individual-patient-data reanalysis of randomized trials found a statistically significant but modest average benefit for esketamine plus an antidepressant at four weeks, with increased sedation, dissociation, and adverse events and uncertainty about clinical magnitude.
How to interpret this record
What it supports
Individual-patient-data reanalysis provides an indication-specific estimate of esketamine efficacy, relapse, and adverse events in randomized trials for treatment-resistant depression.
Major limitations
The average benefit was modest, some analyses had unblinding or selection concerns, and the results depend on supervised formulation, co-treatment, and follow-up.
What it does not establish
The review does not establish take-home ketamine, wellness use, universal remission, or a safe self-directed schedule.